Smiths out, says Medisys
Medisys has terminated its marketing agreement with Smiths Group for the Futura safety syringe after last week's falling-out which followed a further delay in the product's launch.
Medisys has terminated its marketing agreement with Smiths Group for the Futura safety syringe after last week's falling-out which followed a further delay in the product's launch.
CyBio launches a new system designed to help researchers automate cell-based screening of new drug candidates, ADME/Tox and assay development.
The speakers at next month's Manufacturing Excellence Ireland meeting, focusing on automation and control in the pharmaceutical industry, have been announced.
The US Food and Drug Administration (FDA) is set to release an additional interim report later this week on the issue of drug counterfeiting.
Orchid has started a push to expand its business into China with the commissioning of the first phase of a joint venture manufacturing facility.